Literature DB >> 15078062

An examination of the dental utilization practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Mark W Yeazel1, James G Gurney, Kevin C Oeffinger, Pauline A Mitby, Ann C Mertens, Melissa M Hudson, Leslie L Robison.   

Abstract

OBJECTIVES: This study characterized the self-reported dental utilization practice of long-term survivors of childhood cancer, a group at increased risk for treatment-induced dental abnormalities.
METHODS: 9,434 survivors and a comparison group of 3,858 siblings completed a 289-item survey that included a question on when their last dental visit occurred.
RESULTS: Within the last year 60.4 percent of survivors reported a dental visit. The groups less likely to report a recent dental visit include minority subjects, subjects with low levels of educational attainment, subjects with annual household incomes < dollar 20,000, and those without health insurance. No significant differences between survivors and siblings were seen. Male survivors exposed to cranial radiation were slightly more likely than other male survivors to report a recent dental visit (OR = 1.27, 95% CI = 1.12, 1.44).
CONCLUSIONS: The dental utilization practices among survivors of childhood cancer are below recommended levels, even among those at highest risk for dental abnormalities.

Entities:  

Mesh:

Year:  2004        PMID: 15078062     DOI: 10.1111/j.1752-7325.2004.tb02726.x

Source DB:  PubMed          Journal:  J Public Health Dent        ISSN: 0022-4006            Impact factor:   2.258


  7 in total

Review 1.  A systematic review of dental late effects in survivors of childhood cancer.

Authors:  Prasad L Gawade; Melissa M Hudson; Sue C Kaste; Joseph P Neglia; Louis S Constine; Leslie L Robison; Kirsten K Ness
Journal:  Pediatr Blood Cancer       Date:  2013-11-01       Impact factor: 3.167

2.  Impact of insurance type on survivor-focused and general preventive health care utilization in adult survivors of childhood cancer: the Childhood Cancer Survivor Study (CCSS).

Authors:  Jacqueline Casillas; Sharon M Castellino; Melissa M Hudson; Ann C Mertens; Isac S F Lima; Qi Liu; Lonnie K Zeltzer; Yutaka Yasui; Leslie L Robison; Kevin C Oeffinger
Journal:  Cancer       Date:  2010-11-10       Impact factor: 6.860

3.  Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study.

Authors:  Sue C Kaste; Pamela Goodman; Wendy Leisenring; Marilyn Stovall; Robert J Hayashi; Mark Yeazel; Soraya Beiraghi; Melissa M Hudson; Charles A Sklar; Leslie L Robison; K Scott Baker
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

Review 4.  The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.

Authors:  Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

5.  Preventive health services and lifestyle practices in cancer survivors: a population health investigation.

Authors:  Patricia A Findley; Usha Sambamoorthi
Journal:  J Cancer Surviv       Date:  2008-12-10       Impact factor: 4.442

Review 6.  Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort.

Authors:  Paul C Nathan; Jennifer S Ford; Tara O Henderson; Melissa M Hudson; Karen M Emmons; Jacqueline N Casillas; E Anne Lown; Kirsten K Ness; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

7.  Oligomicrodontia in a Pediatric Cancer Survivor after Chemotherapy: A Case Report.

Authors:  Ana Zulijani; Martina Žigante; Luka Morelato; Berislav Perić; Ana Milardović
Journal:  Healthcare (Basel)       Date:  2022-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.